On the mechanism of the sleep-prolonging effect of antimetabolites of nicotinamide.
D000758:Anesthesia; D000818:Animals; D000963:Antimetabolites; D001921:Brain / Q000201:enzymology; D002490:Central Nervous System / Q000187:drug effects; D005954:Glucosephosphate Dehydrogenase / Q000037:antagonists & inhibitors; D006591:Hexobarbital / Q000494:pharmacology; D008291:Malate Dehydrogenase / Q000037:antagonists & inhibitors; D009249:NADP; D009536:Niacinamide; D010243:Paralysis / Q000139:chemically induced; D010428:Pentosephosphates / Q000378:metabolism; D011725:Pyridines / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D012890:Sleep / Q000187:drug effects*
D000963:Antimetabolites; D010428:Pentosephosphates; D011725:Pyridines; D009536:Niacinamide; D009249:NADP; D006591:Hexobarbital; D008291:Malate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase